The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation ; volume:16 ; number:1 ; day:1 ; month:6 ; year:2016 ; pages:1-9 ; date:12.2016
BMC pediatrics ; 16, Heft 1 (1.6.2016), 1-9, 12.2016
- Contributor
-
Collins, Carmel T.
Gibson, Robert A.
Makrides, Maria
McPhee, Andrew J.
Sullivan, Thomas R.
Davis, Peter G.
Thio, Marta
Simmer, Karen
Rajadurai, Victor S.
SpringerLink (Online service)
- DOI
-
10.1186/s12887-016-0611-0
- URN
-
urn:nbn:de:1111-2016060314353
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Collins, Carmel T.
- Gibson, Robert A.
- Makrides, Maria
- McPhee, Andrew J.
- Sullivan, Thomas R.
- Davis, Peter G.
- Thio, Marta
- Simmer, Karen
- Rajadurai, Victor S.
- SpringerLink (Online service)
Other Objects (12)
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation
Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia
The first twelve weeks of gestation
An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks’ gestation: results of the TIPIT trial
Stillborn twins at 26 weeks of gestation
The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
Cord pilot trial - immediate versus deferred cord clamping for very preterm birth (before 32 weeks gestation): study protocol for a randomized controlled trial
Improving the outcome of infants born at <30 weeks' gestation - a randomized controlled trial of preventative care at home
Assisted Physical Exercise for Improving Bone Strength in Preterm Infants Less than 35 Weeks Gestation: A Randomized Controlled Trial
A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation-a feasibility study
Association between early metabolic acidosis and bronchopulmonary dysplasia/death in preterm infants born at less than 28 weeks’ gestation: an observational cohort study
Neurobehaviour between birth and 40 weeks’ gestation in infants born <30 weeks’ gestation and parental psychological wellbeing: predictors of brain development and child outcomes
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation
Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia
The first twelve weeks of gestation
An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks’ gestation: results of the TIPIT trial
Stillborn twins at 26 weeks of gestation
The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
Cord pilot trial - immediate versus deferred cord clamping for very preterm birth (before 32 weeks gestation): study protocol for a randomized controlled trial
Improving the outcome of infants born at <30 weeks' gestation - a randomized controlled trial of preventative care at home
Assisted Physical Exercise for Improving Bone Strength in Preterm Infants Less than 35 Weeks Gestation: A Randomized Controlled Trial
A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation-a feasibility study
Association between early metabolic acidosis and bronchopulmonary dysplasia/death in preterm infants born at less than 28 weeks’ gestation: an observational cohort study
Neurobehaviour between birth and 40 weeks’ gestation in infants born <30 weeks’ gestation and parental psychological wellbeing: predictors of brain development and child outcomes
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation
Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia
The first twelve weeks of gestation
An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks’ gestation: results of the TIPIT trial
Stillborn twins at 26 weeks of gestation
The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
Cord pilot trial - immediate versus deferred cord clamping for very preterm birth (before 32 weeks gestation): study protocol for a randomized controlled trial
Improving the outcome of infants born at <30 weeks' gestation - a randomized controlled trial of preventative care at home
Assisted Physical Exercise for Improving Bone Strength in Preterm Infants Less than 35 Weeks Gestation: A Randomized Controlled Trial
A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation-a feasibility study
Association between early metabolic acidosis and bronchopulmonary dysplasia/death in preterm infants born at less than 28 weeks’ gestation: an observational cohort study